Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
108
days
5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex
AuthorsSubarno Paul; Chinmay Das; Subhasmita Bhal; Saptarshi Sinha; Somya Ranjan Dash; Sushree Subhadra Acharya; Aakash Goswami; Kunal Goutam; Chanakya Nath Kundu; Tithi Parija
Affiliations1. Deemed to Be University; 2. Acharya Harihar Post Graduate Institute of Cancer
84
days
The evolving bioinformatic approaches to identifying genetic targets of promise in cancers
AuthorsVijay Kumar; Darin Mansor Mathkor; Shafiul Haque
Affiliations1. Amity University; 2. Jazan University; 3. Universidad Espiritu Santo
97
days
Tailored strategies to overcome third-generation TKI resistance in EGFR-mutated non-small cell lung cancer
AuthorsIsabella Saporita; Giovanni Farinea; Elisa Lombardi; Paolo Bironzo; Silvia Novello; Francesco Passiglia
Affiliations1. University of Turin, San Luigi Hospital
39
days
APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translation
AuthorsJessica A. Occhiuto; Silpa Gampala; Melissa L. Fishel; Mark R. Kelley
Affiliations1. Indiana University School of Medicine
70
days
Fibroblast activation protein inhibitor-based theranostics in neuroendocrine neoplasms
AuthorsAnna La Salvia; Daniela Lucente; Stefania Bellino
Affiliations1. Istituto Superiore di Sanità
58
days
Possibility to therapeutically exploit RGPR-p117 as a target in cancer cells
AuthorsMasayoshi Yamaguchi
Affiliations1. University of Hawaii Cancer Center, University of Hawaii
94
days
The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances
AuthorsHongying Zhou; Jie Yang; Wenbin Wu; Shizhang Wei; Yanling Zhao; Chunyu Li
Affiliations1. The First Affiliated Hospital of China Medical University; 2. Offices Administration of the Central Military Commission; 3. Chinese Academy of Medical Sciences and Peking Union Medical College; 4. Chinese PLA General Hospital
85
days
Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma
AuthorsXi Chen; Zhengwen Zhang; Siqian Cui; Yiguo Zhang
Affiliations1. Chongqing University; 2. University College London; 3. Chongqing University Jiangjin Hospital
200
days
Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy
AuthorsSaumya Upadhyay; Shyam Sunder Sharma
Affiliations1. National Institute of Pharmaceutical Education and Research
139
days
The protective role of SIRT1 in cardiovascular disease: from molecular mechanisms to potential therapeutic strategies
AuthorsHaixin Ma; Shuya Wang; Zijian Dang; Wentao Xie; Ning Li; Jiayan Li; Yang Yang; Zhenxiao Jin
Affiliations1. Northwest University; 2. The Fourth Military Medical University
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days